ICU Medical

ICU Medical EBIT/Assets

The Operating Income to Assets Ratio (EBIT/Assets) of ICU Medical (ICUI) as of Nov 16, 2026 is 2.64 %. In the previous year, Operating Income to Assets Ratio (EBIT/Assets) was 1.02 % — a change of 158.36% (higher).

EBIT/Assets

2.64 %

YoY

158.36%

Last updated:

Operating Income to Assets Ratio (EBIT/Assets) of ICU Medical is 2025 2.64 % . Operating Income to Assets Ratio (EBIT/Assets) of ICU Medical was 2024 1.02 % . It decreases by 158.36% higher compared to the previous year.

The ICU Medical EBIT/Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT/Assets
Date
EBIT/Assets
Jan 1, 2018
1.36 USD
Jan 1, 2019
6.34 USD
Jan 1, 2020
5.57 USD
Jan 1, 2021
6.55 USD
Jan 1, 2022
-0.95 USD
Jan 1, 2023
0.52 USD
Jan 1, 2024
1.02 USD
Jan 1, 2025
2.64 USD
The ICU Medical EBIT/Assets history
YEAREBIT/AssetsYoY
2.64 %+158.36%
1.02 %+96.05%
0.52 %-154.87%
-0.95 %-114.50%
6.55 %+17.74%
5.57 %-12.26%
6.34 %+365.36%
1.36 %-235.34%
-1.01 %-108.56%
11.77 %+7.60%
10.94 %+51.62%
7.21 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ICU Medical Stock analysis

What does ICU Medical do? ICU Medical Inc is a US medical technology company specializing in the development and production of innovative products for infusion and oncology therapy. It was founded in 1984 by Dr. George A. Lopez and has become a leading manufacturer of disposable products for infusion therapy. The company offers a wide range of disposable products for infusion and oncology therapy, including solutions, medication administration systems, catheters, syringes, tubes, and sensors. They also manufacture medical devices such as syringe pumps, medication administration pumps, and gravity infusion devices. ICU Medical Inc collaborates with other companies in the medical and pharmaceutical industries to provide comprehensive solutions for intravenous therapy. The company's product range includes syringes, tubes, catheters, combination products, infusion and syringe pumps, and the Clave technology for closed infusion pump systems. ICU Medical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ICU Medical stock

Operating Income to Assets Ratio (EBIT/Assets) of ICU Medical is 2.64 % in 2025.

Operating Income to Assets Ratio (EBIT/Assets) of ICU Medical changed from 1.02 % to 2.64 %, representing a 158.36% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Income to Assets Ratio (EBIT/Assets) ICU Medical since 2006 – with annual values, charts, and detailed analysis.

EBIT/Assets measures operating profitability relative to total assets, providing an unlevered view of asset efficiency that is comparable across capital structures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Income to Assets Ratio (EBIT/Assets)'s ICU Medical with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Income to Assets Ratio (EBIT/Assets)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Income to Assets Ratio (EBIT/Assets).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — ICU Medical

All Key Metrics — ICU Medical